Evi Regitz

1.5k total citations
46 papers, 864 citations indexed

About

Evi Regitz is a scholar working on Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Evi Regitz has authored 46 papers receiving a total of 864 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pathology and Forensic Medicine, 19 papers in Radiology, Nuclear Medicine and Imaging and 16 papers in Immunology. Recurrent topics in Evi Regitz's work include Monoclonal and Polyclonal Antibodies Research (19 papers), Lymphoma Diagnosis and Treatment (19 papers) and Chronic Lymphocytic Leukemia Research (13 papers). Evi Regitz is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (19 papers), Lymphoma Diagnosis and Treatment (19 papers) and Chronic Lymphocytic Leukemia Research (13 papers). Evi Regitz collaborates with scholars based in Germany, United States and France. Evi Regitz's co-authors include Michael Pfreundschuh, Klaus‐Dieter Preuss, Natalie Fadle, Frank Neumann, Joerg Thomas Bittenbring, Manfred Ahlgrimm, Bernd Romeike, Gerhard Held, Lorenz Thurner and Boris Kubuschok and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Evi Regitz

42 papers receiving 852 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Evi Regitz Germany 19 354 328 232 164 155 46 864
Laura C. Hooper United States 18 371 1.0× 350 1.1× 214 0.9× 197 1.2× 72 0.5× 24 1.1k
Jonas J. W. Kuiper Netherlands 18 145 0.4× 210 0.6× 99 0.4× 80 0.5× 241 1.6× 52 931
Andrew Galazka Germany 19 139 0.4× 375 1.1× 399 1.7× 418 2.5× 49 0.3× 50 1.1k
DL Longo United States 18 256 0.7× 603 1.8× 323 1.4× 400 2.4× 108 0.7× 31 1.2k
Benjamin E. Rich United States 15 238 0.7× 390 1.2× 84 0.4× 151 0.9× 37 0.2× 29 757
Ernesto Roldán Spain 15 145 0.4× 416 1.3× 451 1.9× 194 1.2× 63 0.4× 26 884
С. В. Лапин Russia 13 130 0.4× 144 0.4× 180 0.8× 76 0.5× 61 0.4× 139 678
Kathleen McKeever United States 13 173 0.5× 278 0.8× 124 0.5× 262 1.6× 310 2.0× 23 777
Rose Beck United States 14 149 0.4× 266 0.8× 188 0.8× 262 1.6× 34 0.2× 49 699
S. Saks United States 17 181 0.5× 313 1.0× 135 0.6× 258 1.6× 73 0.5× 20 815

Countries citing papers authored by Evi Regitz

Since Specialization
Citations

This map shows the geographic impact of Evi Regitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evi Regitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evi Regitz more than expected).

Fields of papers citing papers by Evi Regitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evi Regitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evi Regitz. The network helps show where Evi Regitz may publish in the future.

Co-authorship network of co-authors of Evi Regitz

This figure shows the co-authorship network connecting the top 25 collaborators of Evi Regitz. A scholar is included among the top collaborators of Evi Regitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evi Regitz. Evi Regitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Neumann, Frank, Konstantinos Christofyllakis, Igor Age Kos, et al.. (2024). Hyper-N-glycosylated SEL1L3 as auto-antigenic B-cell receptor target of primary vitreoretinal lymphomas. Scientific Reports. 14(1). 9571–9571. 1 indexed citations
2.
Fadle, Natalie, Evi Regitz, Igor Age Kos, et al.. (2024). Autoantibody mediated deficiency of IL-36-receptor antagonist in a subset of patients with psoriasis and psoriatic arthritis. Immunology Letters. 270. 106926–106926. 2 indexed citations
3.
Christofyllakis, Konstantinos, Dominic Kaddu‐Mulindwa, Igor Age Kos, et al.. (2024). An inherited genetic variant of the CEP72 gene is associated with the development of vincristine-induced peripheral neuropathy in female patients with aggressive B-cell lymphoma. Annals of Hematology. 103(11). 4599–4606. 2 indexed citations
4.
Thurner, Lorenz, Natalie Fadle, Joerg Thomas Bittenbring, et al.. (2021). LRPAP1 autoantibodies in mantle cell lymphoma are associated with superior outcome. Blood. 137(23). 3251–3258. 7 indexed citations
5.
Bewarder, Moritz, Carlos Metz, André Becker, et al.. (2021). Killer immunoglobulin-like receptor 2DS5 is associated with recovery from coronavirus disease 2019. Intensive Care Medicine Experimental. 9(1). 45–45. 4 indexed citations
6.
Kaddu‐Mulindwa, Dominic, Maciej Rosołowski, Marita Ziepert, et al.. (2020). VEGFR2 and VEGFA polymorphisms are not associated with an inferior prognosis in Caucasian patients with aggressive B‐cell lymphoma. European Journal Of Haematology. 106(1). 100–104. 4 indexed citations
7.
Bewarder, Moritz, Stephan Stilgenbauer, Konstantinos Christofyllakis, et al.. (2020). Integration of the B-Cell Receptor Antigen Neurabin-I/SAMD14 Into an Antibody Format as New Therapeutic Approach for the Treatment of Primary CNS Lymphoma. Frontiers in Oncology. 10. 580364–580364. 5 indexed citations
8.
Klemm, Philipp, G. Aßmann, Klaus‐Dieter Preuss, et al.. (2019). Progranulin autoantibodies in systemic sclerosis and autoimmune connective tissue disorders: A preliminary study. Immunity Inflammation and Disease. 7(4). 271–275. 7 indexed citations
9.
Thurner, Lorenz, Sylvia Hartmann, Natalie Fadle, et al.. (2018). LRPAP1 is a frequent proliferation-inducing antigen of BCRs of mantle cell lymphomas and can be used for specific therapeutic targeting. Leukemia. 33(1). 148–158. 17 indexed citations
10.
Thurner, Lorenz, Sylvia Hartmann, Klaus‐Dieter Preuss, et al.. (2015). LRPAP1 Is a Frequent B-Cell Receptor Antigen in Mantle Cell Lymphoma (MCL). Blood. 126(23). 2685–2685. 1 indexed citations
11.
Thurner, Lorenz, Natalie Fadle, Philipp Klemm, et al.. (2014). Proinflammatory Progranulin Antibodies in Inflammatory Bowel Diseases. Digestive Diseases and Sciences. 59(8). 1733–1742. 37 indexed citations
12.
Thurner, Lorenz, Klaus‐Dieter Preuss, Natalie Fadle, et al.. (2012). Progranulin antibodies in autoimmune diseases. Journal of Autoimmunity. 42. 29–38. 55 indexed citations
14.
Preuss, Klaus‐Dieter, Michael Pfreundschuh, Manfred Ahlgrimm, et al.. (2009). A frequent target of paraproteins in the sera of patients with multiple myeloma and MGUS. International Journal of Cancer. 125(3). 656–661. 33 indexed citations
16.
Pföhler, Claudia, Klaus‐Dieter Preuss, Wolfgang Tilgen, et al.. (2006). Mitofilin and titin as target antigens in melanoma‐associated retinopathy. International Journal of Cancer. 120(4). 788–795. 22 indexed citations
17.
Mischo, Axel, Boris Kubuschok, Kubilay Ertan, et al.. (2005). Prospective study on the expression of cancer testis genes and antibody responses in 100 consecutive patients with primary breast cancer. International Journal of Cancer. 118(3). 696–703. 71 indexed citations
18.
Kubuschok, Boris, Ralf Jesnowski, Klaus‐Dieter Preuss, et al.. (2004). Expression of cancer testis antigens in pancreatic carcinoma cell lines, pancreatic adenocarcinoma and chronic pancreatitis. International Journal of Cancer. 109(4). 568–575. 41 indexed citations
19.
Preuss, Klaus‐Dieter, et al.. (2002). Analysis of the antibody repertoire of lymphoma patients. Cancer Immunology Immunotherapy. 51(11-12). 655–662. 33 indexed citations
20.
Schmits, Rudolf, Björn Cochlovius, Evi Regitz, et al.. (2001). Analysis of the antibody repertoire of astrocytoma patients against antigens expressed by gliomas. International Journal of Cancer. 98(1). 73–77. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026